Swedish Orphan Biovitrum AB (publ) Eulerpool News

Swedish Orphan Biovitrum AB (publ) Eulerpool-AFX

Swedish Orphan Biovitrum AB (publ) Stock News

Swedish Orphan Biovitrum AB (publ) is being monitored by journalists and investors worldwide. We gather the latest Swedish Orphan Biovitrum AB (publ) news here.

• May 24 ·

  Yahoo
  Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
• May 24 ·

  Yahoo
  Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
• May 24 ·

  Yahoo
  Positive data from phase 2 NOBLE study of pegcetacoplan presented as late-breaker at ERA congress
• May 24 ·

  Yahoo
  Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress
• May 24 ·

  Thefly.com
  Apellis, Sobi present one-year data from Phase 2 study of pegcetacoplan
• May 9 ·

  Yahoo
  Sobi’s Aspaveli obtains indication extension approval in Europe
• May 8 ·

  Yahoo
  Sobi has completed SEK 3 billion senior bond issue
• April 26 ·

  Yahoo
  Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
• April 26 ·

  Thefly.com
  SEB Equities gets more bearish on Swedish Orphan Biovitrum, downgrades shares
• April 25 ·

  SeekingAlpha
  Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2024 Earnings Call Transcript